Abstract A boy, aged 4 months, had the major clinical manifestations of prolonged jaundice and hepatomegaly. Multiple biochemical tests revealed abnormal liver function along with elevated alpha-fetoprotein and lactate. Genetic analysis confirmed that the boy had the mutations of c.589C > T(p.Gln197Ter) and c.687G > C(p.Trp229Cys) in the DGUOK gene, both of which were novel mutations and were determined to be pathogenic and likely pathogenic respectively, by a variety of bioinformatics tools and the ACMG standard. Therefore, the boy was confirmed to have DGUOK-related mitochondrial DNA depletion syndrome. Literature review showed that onset of liver disease in infancy was the main clinical feature of this disease, and some children presented with nervous system manifestations. Abnormal laboratory results included abnormal liver function, increases in blood lactate, serum ferritin and alpha-fetoprotein, and hypoglycemia. Such children had marked heterogeneity of DGUOK gene mutations, with missense mutations as the most common type. This disease tended to have a poor prognosis, and 79.6% of the children died before the age of 3 years.
LIN Gui-Zhi,QIU Jian-Wu,DENG Mei et al. DGUOK-related mitochondrial DNA depletion syndrome: a case report and literature review[J]. CJCP, 2020, 22(3): 274-279.
LIN Gui-Zhi,QIU Jian-Wu,DENG Mei et al. DGUOK-related mitochondrial DNA depletion syndrome: a case report and literature review[J]. CJCP, 2020, 22(3): 274-279.
El-Hattab AW, Craigen WJ, Scaglia F. Mitochondrial DNA maintenance defects[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(6):1539-1555.
[2]
Bennett B, Helbling D, Meng H, et al. Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome[J]. Free Radic Biol Med, 2016, 92:141-151.
[3]
Kim J, Kang E, Kim Y, et al. MPV17 mutations in patients with hepatocerebral mitochondrial DNA depletion syndrome[J]. Mol Genet Metab Rep, 2016, 8:74-76.
[4]
Pronicka E, Węglewska-Jurkiewicz A, Taybert J, et al. Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure[J]. J Appl Genet, 2011, 52(1):61-66.
[5]
Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA[J]. Nat Genet, 2001, 29(3):337-341.
[6]
Ji JQ, Dimmock D, Tang LY, et al. A novel c.592-4_c.592-3delTT mutation in DGUOK gene causes exon skipping[J]. Mitochondrion, 2010, 10(2):188-191.
[7]
Spinazzola A, Invernizzi F, Carrara F, et al. Clinical and molecular features of mitochondrial DNA depletion syndromes[J]. J Inherit Metab Dis, 2009, 32(2):143-158.
[8]
Fang W, Song P, Xie X, et al. A fatal case of mitochondrial DNA depletion syndrome with novel compound heterozygous variants in the deoxyguanosine kinase gene[J]. Oncotarget, 2017, 8(48):84309-84319.
[9]
Haudry C, de Lonlay P, Malan V, et al. Maternal uniparental disomy of chromosome 2 in a patient with a DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome[J]. Mol Genet Metab, 2012, 107(4):700-704.
[10]
Waich S, Roscher A, Brunner-Krainz M, et al. Severe DGUOK deficiency in Austria:a six-patient series[J]. J Pediatr Gastroenterol Nutr, 2018, 68(1):e1-e6.
[11]
Ünal Ö, Hişmi B, Kılıç M, et al. Deoxyguanosine kinase deficiency:a report of four patients[J]. J Pediatr Endocrinol Metab, 2017, 30(6):697-702.
[12]
Grabhorn E, Tsiakas K, Herden U, et al. Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency:a single-center experience and a review of the literature[J]. Liver Transpl, 2014, 20(4):464-472.
[13]
Sezer T, Ozcay F, Balci O, et al. Novel deoxyguanosinekinase gene mutations in the hepatocerebralform of mitochondrial DNA depletion syndrome[J]. J Child Neurol, 2015, 30(1):124-128.
[14]
Al-Hussaini A, Faqeih E, El-Hattab AW, et al. Clinical and molecular characteristics of mitochondrial DNA depletion syndrome associated with neonatal cholestasis and liver failure[J]. J Pediatr, 2014, 164(3):553-559.
[15]
Yamazaki T, Murayama K, Compton AG, et al. Molecular diagnosis of mitochondrial respiratory chain disorders in Japan:focusing on mitochondrial DNA depletion syndrome[J]. Pediatr Int, 2014, 56(2):180-187.
[16]
Kasapkara CS, Tümer L, Küçükçongar A, et al. DGUOK-related mitochondrial DNA depletion syndrome in a child with an early diagnosis of glycogen storage disease[J]. J Pediatr Gastroenterol Nutr, 2013, 57(5):e28-e29.
[17]
Nobre S, Grazina M, Silva F, et al. Neonatal liver failure due to deoxyguanosine kinase deficiency[J]. BMJ Case Rep, 2012, 2012. pii:bcr1220115317.
[18]
Mudd SH, Wagner C, Luka Z, et al. Two patients with hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and methionine[J]. Mol Genet Metab, 2012, 105(2):228-236.
[19]
Douglas GV, Wiszniewska J, Lipson MH, et al. Detection of uniparental isodisomy in autosomal recessive mitochondrial DNA depletion syndrome by high-density SNP array analysis[J]. J Hum Genet, 2011, 56(12):834-839.
[20]
Kiliç M, Sivri HS, Dursun A, et al. A novel mutation in the DGUOK gene in a Turkish newborn with mitochondrial depletion syndrome[J]. Turk J Pediatr, 2011, 53(1):79-82.
[21]
Hanchard NA, Shchelochkov OA, Roy A, et al. Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis[J]. Mol Genet Metab, 2011, 103(3):262-267.
[22]
Brahimi N, Jambou M, Sarzi E, et al. The first founder DGUOK mutation associated with hepatocerebral mitochondrial DNA depletion syndrome[J]. Mol Genet Metab, 2009, 97(3):221-226.
[23]
Lee NC, Dimmock D, Hwu WL, et al. Simultaneous detection of mitochondrial DNA depletion and single-exon deletion in the deoxyguanosine gene using array-based comparative genomic hybridisation[J]. Arch Dis Child, 2009, 94(1):55-58.
[24]
Dimmock DP, Zhang Q, Dionisi-Vici C, et al. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase[J]. Hum Mutat, 2008, 29(2):330-331.
[25]
Mousson de Camaret B, Taanman JW, Padet S, et al. Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion[J]. Biochem J, 2007, 402(2):377-385.
[26]
Freisinger P, Fütterer N, Lankes E, et al. Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations[J]. Arch Neurol, 2006, 63(8):1129-1134.
[27]
Slama A, Giurgea I, Debrey D, et al. Deoxyguanosine kinase mutations and combined deficiencies of the mitochondrial respiratory chain in patients with hepatic involvement[J]. Mol Genet Metab, 2005, 86(4):462-465.
[28]
Tadiboyina VT, Rupar A, Atkison P, et al. Novel mutation in DGUOK in hepatocerebral mitochondrial DNA depletion syndrome associated with cystathioninuria[J]. Am J Med Genet A, 2005, 135(3):289-291.
[29]
Taanman JW, Kateeb I, Muntau AC, et al. A novel mutation in the deoxyguanosine kinase gene causing depletion of mitochondrial DNA[J]. Ann Neurol, 2002, 52(2):237-239.
[30]
Mancuso M, Ferraris S, Pancrudo J, et al. New DGK gene mutations in the hepatocerebral form of mitochondrial DNA depletion syndrome[J]. Arch Neurol, 2005, 62(5):745-747.
[31]
Diogo L, Grazina M, Garcia P, et al. Pediatric mitochondrial respiratory chain disorders in the Centro region of Portugal[J]. Pediatr Neurol, 2009, 40(5):351-356.
[32]
Salviati L, Sacconi S, Mancuso M, et al. Mitochondrial DNA depletion and dGK gene mutations[J]. Ann Neurol, 2010, 52(3):311-317.
[33]
Al-Shamsi A, Hertecant JL, Al-Hamad S, et al. Mutation spectrum and birth prevalence of inborn errors of metabolism among emiratis:a study from Tawam Hospital Metabolic Center, United Arab Emirates[J]. Sultan Qaboos Univ Med J, 2014, 14(1):e42-e49.
[34]
Sarzi E, Bourdon A, Chrétien D, et al. Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood[J]. J Pediatr, 2007, 150(5):531-534.
[35]
Wang L, Limongelli A, Vila MR, et al. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes[J]. Mol Genet Metab, 2005, 84(1):75-82.
[36]
Mancuso M, Filosto M, Tsujino S, et al. Muscle glycogenosis and mitochondrial hepatopathy in an infant with mutations in both the myophosphorylase and deoxyguanosine kinase genes[J]. Arch Neurol, 2003, 60(10):1445-1447.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants:a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5):405-423.
[39]
Mahjoub G, Habibzadeh P, Dastsooz H, et al. Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome:a case series[J]. BMC Med Genet, 2019, 20(1):167.
[40]
El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes:review and updates of genetic basis, manifestations, and therapeutic options[J]. Neurotherapeutics, 2013, 10(2):186-198.1.